ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
AMAL Therapeutics Finalises €29 Million (CHF 33.2 Million) Series B Round
b3cnewswire
November 12, 2018The Company will use the funds to progress its lead vaccine (ATP128) toward clinical development and proof-of-concept in colorectal cancer, a leading cause of mortality and a significant market opportunity (€9.6 billion by 2025). The clinical trial is exp -
Syncona powers gene therapy startup Freeline to ￡88M B round
fiercebiotech
June 25, 2018Syncona has?dialed up?its bet on gene therapy startup Freeline Therapeutics. The life science investor committed ￡85 million ($112 million) to Freeline’s ￡88 million series B round, thereby maintaining a big stake in a biotech that is working to redefine
Pharma Sources Insight January 2025
